RxDoctor Payments Data

Marie Scott, NP

Adult Health · Celebration, FLNPI 1467943803

Payments from drug & device makers

$6,956in general payments, 2019–2025

Across 351 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$564
  • Bristol Myers Squibb$318
  • Gilead$303
  • Takeda Pharmaceuticals U.S.A., Inc.$295
  • Intercept Pharmaceuticals, Inc.$279
  • plus $3K from 21 others

What the payments were for

  • Food & beverage$6,85799%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,956 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$47,556
Medicare patients
310
Services billed
429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase39$108,531
LinzessLinaclotide36$40,669
SutabSod Sulf/Pot Chloride/Mag Sulf61$9,922
Colesevelam Hcl21$9,557
Pantoprazole Sodium204$2,412
Omeprazole70$1,159
Lactulose49$1,044
Sucralfate31$1,037
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates16$855
Famotidine60$677
Dicyclomine Hcl33$526
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl36$521
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg20$456
Esomeprazole Magnesium12$410
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl12$201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$2,352$149,20075 claims
Braintree Laboratories, Inc.Sutab$56$9,92261 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.

Other adult health in Celebration

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →